Stock EARUM MURAE ORGANISOR LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Murae Organisor Limited

Equities

EARUM

INE060601023

Delayed Bombay S.E.
Other stock markets
 07:45:00 27/06/2024 BST 		5-day change 1st Jan Change
1.42 INR +1.43% Intraday chart for Murae Organisor Limited -2.74% +23.48%
05-30 Murae Organisor Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
05-29 Murae Organisor Limited announced that it has received INR 247.499999 million in funding from IFL Enterprises Limited, Moneystar Tradelink Private Limited, Banke Tradelink Private Limited, Balmukund Tradelink Private Limited, Someshwara Tradelink Private Limited CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Murae Organisor Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Murae Organisor Limited Announces Board Appointments
Murae Organisor Limited Appoints Sangita Rajpurohit as Company Secretary and Compliance Officer
Earum Pharmaceuticals Limited Approves Board Resignations
Earum Pharmaceuticals Limited Announces Resignation of Sanjaykumar Nai as Non-Executive Director
Earum Pharmaceuticals Limited Announces Resignation of Vijaykumar Patel as Managing Director
Earum Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Earum Pharmaceuticals Limited Approves Board Changes
Earum Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Earum Pharmaceuticals Limited Announces Executive Changes
Earum Pharmaceuticals Limited Announces Resignation of Directors
Earum Pharmaceuticals Limited Announces Resignation of Madhuri Mistry from the Position of the Company Secretary
Earum Pharmaceuticals Limited's Board intends to launch an Equity Buyback on July 14, 2023
E Earum Pharmaceuticals Limited Approves the Proposal for Opening of Three Overseas Branch Offices
Earum Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
Earum Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Earum Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Earum Pharmaceuticals Limited Appoints Sumitkumar Patel as Independent Director, with Effect from 5Th November, 2022
Earum Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Earum Pharmaceuticals Limited Appoints Madhuri Mistry as the Company Secretary and Compliance Officer
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EARUM Stock
  4. News Murae Organisor Limited
  5. Other languages